H-1B sponsorNYFEIN 13-3444607Updated Jun 2026
Regeneron Pharmaceuticals, Inc.
US H-1B Labor Condition Application activity for Regeneron Pharmaceuticals, Inc.. Filed 1,137 disclosures between FY2010 and FY2026 from worksites with a NY headquarters indicator.
Total filings
199
Outside top-N · FY2026
Certified
99.5%
unconditional · FY2026
Withdrawn
0.5%
withdrawn rate · FY2026
Denied
0.0%
rejection rate · FY2026
H-1B outcome breakdown
Share of Regeneron Pharmaceuticals, Inc.’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.
| Outcome | Share |
|---|---|
| Certified | 99.2% |
| Cert-withdrawn | 0.2% |
| Withdrawn | 0.7% |
Certified99.2%
Cert-withdrawn0.2%
Withdrawn0.7%
Top occupations sponsored
SOC codes filed most by Regeneron Pharmaceuticals, Inc. across all fiscal years. Click any row to open the national salary guide.
| # | SOC | Title | Filings |
|---|---|---|---|
| 1 | 19-1042 | Medical Scientists, Except Epidemiologists | 236 |
| 2 | 15-2041 | Statisticians | 97 |
| 3 | 19-4021 | Biological Technicians | 93 |
| 4 | 15-1252 | Software Developers | 59 |
| 5 | 19-1029 | Biological Scientists, All Other | 56 |
| 6 | 19-1022 | Microbiologists | 53 |
| 7 | 19-1021 | Biochemists and Biophysicists | 52 |
| 8 | 19-2021 | Atmospheric and Space Scientists | 43 |
| 9 | 15-1299 | Computer Occupations, All Other | 32 |
| 10 | 15-2051 | Data Scientists | 31 |
Medical Scientists, Except Epidemiologists
236
Statisticians
97
Biological Technicians
93
Software Developers
59
Biological Scientists, All Other
56
Microbiologists
53
Biochemists and Biophysicists
52
Atmospheric and Space Scientists
43
Computer Occupations, All Other
32
Data Scientists
31
H-1B filings by fiscal year
Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.
| Year | Filings |
|---|---|
| FY2010 | 50 |
| FY2011 | 37 |
| FY2012 | 40 |
| FY2013 | 43 |
| FY2014 | 43 |
| FY2015 | 39 |
| FY2016 | 47 |
| FY2017 | 62 |
| FY2018 | 80 |
| FY2019 | 99 |
| FY2020 | 24 |
| FY2021 | 19 |
| FY2022 | 24 |
| FY2023 | 42 |
| FY2024 | 130 |
| FY2025 | 159 |
| FY2026 | 199 |
| Period | Value |
|---|---|
| FY2010 | 50 |
| FY2011 | 37 |
| FY2012 | 40 |
| FY2013 | 43 |
| FY2014 | 43 |
| FY2015 | 39 |
| FY2016 | 47 |
| FY2017 | 62 |
| FY2018 | 80 |
| FY2019 | 99 |
| FY2020 | 24 |
| FY2021 | 19 |
| FY2022 | 24 |
| FY2023 | 42 |
| FY2024 | 130 |
| FY2025 | 159 |
| FY2026 | 199 |
Compare Regeneron Pharmaceuticals, Inc. with another sponsor
Side-by-side view of KPIs, outcomes, top breakdowns and yearly trend.
Explore by rank
Pre-built leaderboards for the most-asked questions.
Understand the data
Definitions and methodology behind these H-1B figures.